Catalyst Wire Dossier Catalyst Wire Dossier

Mesenchymal stem cell-derived exosome therapy

exosome therapy · Vitti Labs, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mesenchymal stem cell-derived exosome therapy, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI) [Phase 1]

See pricing